Package 60505-3252-3

{"route": ["ORAL"], "spl_id": "2cca5476-aba6-0525-0bb5-890f2ca25bb7", "openfda": {"nui": ["N0000175656", "N0000175462", "N0000009947"], "unii": ["2T8Q726O95"], "rxcui": ["199147", "349491"], "spl_set_id": ["34c02bcc-d6ff-99d4-8e6a-4a91908adca8"], "pharm_class_epc": ["Hepatitis B Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC]", "Human Immunodeficiency Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC]"], "pharm_class_moa": ["Nucleoside Reverse Transcriptase Inhibitors [MoA]"], "manufacturer_name": ["Apotex Corp."], "is_original_packager": [true]}, "finished": true, "packaging": [{"sample": false, "description": "30 TABLET, FILM COATED in 1 BOTTLE (60505-3252-3)", "package_ndc": "60505-3252-3", "marketing_start_date": "20111202"}, {"sample": false, "description": "1000 TABLET, FILM COATED in 1 BOTTLE (60505-3252-8)", "package_ndc": "60505-3252-8", "marketing_start_date": "20111202"}], "brand_name": "LAMIVUDINE", "product_id": "60505-3252_2cca5476-aba6-0525-0bb5-890f2ca25bb7", "dosage_form": "TABLET, FILM COATED", "pharm_class": ["Hepatitis B Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC]", "Human Immunodeficiency Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC]", "Nucleoside Reverse Transcriptase Inhibitors [MoA]"], "product_ndc": "60505-3252", "generic_name": "lamivudine", "labeler_name": "Apotex Corp.", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "LAMIVUDINE", "active_ingredients": [{"name": "LAMIVUDINE", "strength": "300 mg/1"}], "application_number": "ANDA091606", "marketing_category": "ANDA", "marketing_start_date": "20111202", "listing_expiration_date": "20261231"}